Literature DB >> 17707085

Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program.

Conor Kevin Farren1, Sharon Mc Elroy.   

Abstract

BACKGROUND: Depressed and bipolar alcoholics represent a significant affective subgroup that has a poorer prognosis than either diagnosis alone. To date few systematic treatment programs have been developed to treat dual diagnosis.
METHODS: An inpatient treatment program was developed at St Patrick's Hospital Dublin to treat dual diagnosis clients with alcohol dependence and either unipolar or bipolar affective disorder. Clients (N=232) were assessed for depression, anxiety, elation, cravings, drink and drug intake on admission, discharge, 3 and 6 months post-discharge from the program.
RESULTS: In the overall group there was a reduction in number of drinking days and units per drinking day over the study (p<.01). There was a 71.8% complete abstinent rate at 3 months and 55.8% at 6 months in the depression group, non-significantly greater than for the bipolar group at 64.7% and 54.1% respectively. Gamma GT, MCV and craving scores were significantly reduced over time (p<.01). Mania, depression and anxiety inventory scores fell over time in both groups (p<.01). 15-21-year olds were more severely anxious, had higher illicit drug use, and were more likely to relapse to drug use than older clients. Bipolar 1 clients were significantly more likely than bipolar 2 clients to be on mood stabilisers at all follow-up stages (p<.001). LIMITATIONS: No control group was used.
CONCLUSIONS: There is evidence for efficacy of a specifically designed dual diagnosis inpatient treatment program as both depressed and bipolar alcoholics had significant reductions in all measurements of mood, craving, and alcohol/drug consumption by self report and biological markers, suggesting both diagnoses can be effectively treated together.

Entities:  

Mesh:

Year:  2007        PMID: 17707085     DOI: 10.1016/j.jad.2007.07.006

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.

Authors:  Jean-Michel Azorin; Charles L Bowden; Ricardo P Garay; Giulio Perugi; Eduard Vieta; Allan H Young
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

Review 2.  Bipolar disorder and alcohol use disorder: a review.

Authors:  Conor K Farren; Kevin P Hill; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.

Authors:  Angelo Giovanni Icro Maremmani; Silvia Bacciardi; Luca Rovai; Fabio Rugani; Enrico Massimetti; Denise Gazzarrini; Liliana Dell'Osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2014-12-12       Impact factor: 3.390

4.  Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial.

Authors:  Dan Hartnett; Edel Murphy; Elizabeth Kehoe; Vincent Agyapong; Declan M McLoughlin; Conor Farren
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

5.  Genome-wide association study of psychiatric and substance use comorbidity in Mexican individuals.

Authors:  José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Marycarmen Bustos-Gamiño; Isela Esther Juárez-Rojop; Carlos Alfonso Tovilla-Zarate; Emmanuel Sarmiento; Erasmo Saucedo; Oscar Rodríguez-Mayoral; Clara Fleiz-Bautista; Beatriz Camarena; Alejandro Aguilar; Thelma Beatriz Gonzalez-Castro; María Elena Medina-Mora; Humberto Nicolini
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

6.  Association of FAAH p.Pro129Thr and COMT p.Ala72Ser with schizophrenia and comorbid substance use through next-generation sequencing: an exploratory analysis.

Authors:  José J Martínez-Magaña; Alma D Genis-Mendoza; Vanessa González-Covarrubias; Isela E Juárez-Rojop; Carlos A Tovilla-Zárate; Xavier Soberón; Nuria Lanzagorta; Humberto Nicolini
Journal:  Braz J Psychiatry       Date:  2022 Mar-Abr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.